Restricted Stock, Performance Share and Cash Awards	6 Months Ended
Jun. 30, 2022
Text Block [Abstract]
Restricted Stock, Performance Share and Cash Awards	11. Restricted Stock, Performance Share and Cash Awards Restricted Stock Awards As discussed in Note 9 to these unaudited consolidated financial statements, on May 10, 2022, our stockholders approved the LTIP, which replaced our previous stockholder-approved 2017 LTIP. The LTIP provides for the grant of a stock award either as restricted stock or as restricted stock units to officers, employees and non-employee directors. In either case, the compensation committee may determine that the award will be subject to the attainment of performance measures over an established performance period. Stock awards and the related dividend equivalents are non-transferable and subject to forfeiture if the holder does not remain continuously employed with us during the applicable restriction period or, in the case of a performance-based award, if applicable performance measures are not attained. The compensation committee will determine all of the terms relating to the satisfaction of performance measures and the termination of a restriction period, or the forfeiture and cancellation of a restricted stock award upon a termination of employment, whether by reason of disability, retirement, death or any other reason. The agreements awarding restricted stock units under the LTIP will specify whether such awards may be settled in shares of our common stock, cash or a combination of shares and cash and whether the holder will be entitled to receive dividend equivalents, on a current or deferred basis, with respect to such award. Prior to the settlement of a restricted stock unit, the holder of a restricted stock unit will have no rights as a stockholder of the company. The maximum number of shares available under the LTIP for restricted stock, restricted stock units and performance unit awards settled with stock (i.e., all awards other than stock options and stock appreciation rights) is 4.0 million. At June 30, 2022, 3.3 million shares were available for grant under the LTIP for such awards. In first quarter 2022, we granted 335,000 restricted stock units to employees under the 2017 LTIP, with an aggregate fair value of $52.6 million at the date of grant. These 2022 awards of restricted stock units vest in full based on continued employment through February 1, 2027. Additionally, in the first quarters of 2022 and 2021, we granted 295,000 and 314,000 restricted stock units, respectively, to employees under the 2017 LTIP, with an aggregate fair value of $46.8 million and $40.1 million, respectively, at the date of grant. These 2022 and 2021 awards of restricted stock units vest in full based on continued employment through March 15, 2027 and March 16, 2026, respectively. For our executive officers age 55 or older, restricted stock units are not subject to forfeiture upon such officers’ departure from the company after two years from the date of grant. We account for restricted stock awards at historical cost, which equals its fair market value at the date of grant, which is amortized to compensation expense ratably over the vesting period of the participants. Future changes in the fair value of our common stock that is owed to the participants do not have any impact on the amounts recorded in our consolidated financial statements. During the three-month periods ended June 30, 2022 and 2021, we recognized $10.1 million and $7.6 million, respectively, to compensation expense related to restricted stock unit awards granted in 2016 through 2022. During the six-month periods ended June 30, 2022 and 2021, we recognized $17.7 million and $13.5 million, respectively, to compensation expense related to restricted stock unit awards granted in 2016 through 2022. The total intrinsic value of unvested restricted stock units at June 30, 2022 and 2021 was $353.1 million and $269.7 million, respectively. During the three-month periods ended June 30, 2022 and 2021, equity awards (including accrued dividends) with an aggregate value of $1.2 million and $1.3 million, respectively, were vested and distributed to employees under this plan. During the six-month periods ended June 30, 2022 and 2021, equity awards (including accrued dividends) with an aggregate value of $62.0 million and $48.1 million, respectively, were vested and distributed to employees under this plan. Performance Share Awards On March 15, 2022 and March 16, 2021, pursuant to the 2017 LTIP, the compensation committee approved 54,000 and 67,000, respectively, of provisional performance share awards, with an aggregate fair value of $8.6 million and $8.6 million, respectively, for future grants to our officers. Each performance share award was equivalent to the value of one share of our common stock on the date such provisional award was approved. At the end of the performance period, eligible participants will receive a number of earned shares based on the growth in adjusted EBITDAC per share (as defined in our 2022 Proxy Statement). Earned shares for the 2022 and 2021 provisional awards will fully vest based on continuous employment through March 15, 2025 and March 16, 2024, respectively, and will be settled in unrestricted shares of our common stock on a one-for-one basis as soon as practicable thereafter. The 2022 and 2021 awards are subject to a three-year performance period that began on January 1, 2022 and 2021, respectively, and vest on the three-year anniversary of the date of grant (March 15, 2025 and March 16, 2024). For certain of our executive officers age 55 or older, awards are no longer subject to forfeiture upon such officers’ departure from the company after two years from the date of grant. During the three-month periods ended June 30, 2022 and 2021, we recognized $3.7 million and $3.2 million, respectively, to compensation expense related to performance share awards granted in 2018 through 2022. During the six-month periods ended June 30, 2022 and 2021, we recognized $7.5 million and $6.2 million, respectively, to compensation expense related to performance share awards granted in 2018 through 2022. The total intrinsic value of unvested performance share awards at June 30, 2022 and 2021 was $54.2 million and $55.0 million, respectively. During the six-month periods ended June 30, 2022 and 2021, equity awards (including accrued dividends) with an aggregate fair value of $21.8 million and $19.1 million, respectively, were vested and distributed to employees under this plan. Cash Awards On March 15, 2022, pursuant to our Performance Unit Program (which we refer to as the Program), the compensation committee approved provisional cash awards of $19.9 million in the aggregate for future grants to our officers and key employees that are denominated in units (125,000 units in the aggregate), each of which was equivalent to the value of one share of our common stock on the date the provisional award was approved. The Program consists of a one-year performance period based on our financial performance and a three-year vesting period measured from January 1 of the year of grant. At the discretion of the compensation committee and determined based on our performance, the eligible officer or key employee will be granted a percentage of the provisional cash award units that equates to the EBITAC growth achieved (as defined in the Program). At the end of the performance period, eligible participants will be granted a number of units based on achievement of the performance goal and subject to approval by the compensation committee. Granted units for the 2022 provisional award will fully vest based on continuous employment through January 1, 2025. The ultimate award value will be equal to the trailing twelve-month price of our common stock on December 31, 2024, multiplied by the number of units subject to the award, but limited to between 0.5 and 1.5 times the original value of the units determined as of the grant date. The fair value of the awarded units will be paid out in cash as soon as practicable in 2025. If an eligible employee leaves us prior to the vesting date, the entire award will be forfeited. We did not recognize any compensation expense during the six-month period ended June 30, 2022 related to the 2022 provisional award under the Program. On March 16, 2021, pursuant to the Program, the compensation committee approved provisional cash awards of $18.8 million in the aggregate for future grants to our officers and key employees that are denominated in units (147,000 units in the aggregate), each of which was equivalent to the value of one share of our common stock on the date the provisional award was approved. Terms of the 2021 provisional awards were similar to the terms of the 2022 provisional awards. Based on our performance for 2021, we granted 143,000 units under the Program in the first quarter of 2022 that will fully vest on January 1, 2024. During the three and six-month periods ended June 30, 2022, we recognized $2.9 million and $5.5 million, respectively, to compensation expense related to these awards. On March 12, 2020, pursuant to the Program, the compensation committee approved provisional cash awards of $18.4 million in the aggregate for future grants to our officers and key employees that are denominated in units (213,000 units in the aggregate), each of which was equivalent to the value of one share of our common stock on the date the provisional award was approved. Terms of the 2020 provisional awards were similar to the terms of the 2022 provisional awards. Based on our performance for 2020, we granted 208,000 units under the Program in the first quarter of 2021 that will fully vest on January 1, 2023. During the three-month periods ended June 30, 2022 and 2021, we recognized $2.9 million and $2.3 million, respectively, to compensation expense related to these awards. During the six-month periods ended June 30, 2022 and 2021, we recognized $6.0 million and $5.2 million, respectively, to compensation expense related to these awards. On March 14, 2019, pursuant to the Program, the compensation committee approved provisional cash awards of $16.5 million in the aggregate for future grants to our officers and key employees that are denominated in units (206,800 units in the aggregate), each of which was equivalent to the value of one share of our common stock on the date the provisional award was approved. Terms of the 2019 provisional awards were similar to the terms of the 2022 provisional awards. Based on our performance for 2019, we granted 200,000 units under the Program in the first quarter of 2020 that fully vested on January 1, 2022. During the three and six-month periods ended June 30, 2021, we recognized $1.9 million and $5.1 million to compensation expense related to these awards, respectively. During the six-month period ended June 30, 2022, cash awards related to the 2019 provisional award with an aggregate fair value of $21.1 million (177,000 units in the aggregate) were vested and distributed to employees under the program. During the six-month period ended June 30, 2021, cash awards related to the 2018 provisional award with an aggregate fair value of $17.7 million (176,300 units in the aggregate) were vested and distributed to employees under the Program.

Restricted Stock, Performance Share and Cash Awards

6 Months Ended

Jun. 30, 2022

Restricted Stock, Performance Share and Cash Awards

11. Restricted Stock, Performance Share and Cash Awards

Restricted Stock Awards

As discussed in Note 9 to these unaudited consolidated financial statements, on May 10, 2022, our stockholders approved the LTIP, which replaced our previous stockholder-approved 2017 LTIP. The LTIP provides for the grant of a stock award either as restricted stock or as restricted stock units to officers, employees and non-employee directors. In either case, the compensation committee may determine that the award will be subject to the attainment of performance measures over an established performance period. Stock awards and the related dividend equivalents are non-transferable and subject to forfeiture if the holder does not remain continuously employed with us during the applicable restriction period or, in the case of a performance-based award, if applicable performance measures are not attained. The compensation committee will determine all of the terms relating to the satisfaction of performance measures and the termination of a restriction period, or the forfeiture and cancellation of a restricted stock award upon a termination of employment, whether by reason of disability, retirement, death or any other reason.

The agreements awarding restricted stock units under the LTIP will specify whether such awards may be settled in shares of our common stock, cash or a combination of shares and cash and whether the holder will be entitled to receive dividend equivalents, on a current or deferred basis, with respect to such award. Prior to the settlement of a restricted stock unit, the holder of a restricted stock unit will have no rights as a stockholder of the company. The maximum number of shares available under the LTIP for restricted stock, restricted stock units and performance unit awards settled with stock (i.e., all awards other than stock options and stock appreciation rights) is 4.0 million. At June 30, 2022, 3.3 million shares were available for grant under the LTIP for such awards.

In first quarter 2022, we granted 335,000 restricted stock units to employees under the 2017 LTIP, with an aggregate fair value of $52.6 million at the date of grant. These 2022 awards of restricted stock units vest in full based on continued employment through February 1, 2027. Additionally, in the first quarters of 2022 and 2021, we granted 295,000 and 314,000 restricted stock units, respectively, to employees under the 2017 LTIP, with an aggregate fair value of $46.8 million and $40.1 million, respectively, at the date of grant. These 2022 and 2021 awards of restricted stock units vest in full based on continued employment through March 15, 2027 and March 16, 2026, respectively. For our executive officers age 55 or older, restricted stock units are not subject to forfeiture upon such officers’ departure from the company after two years from the date of grant.

We account for restricted stock awards at historical cost, which equals its fair market value at the date of grant, which is amortized to compensation expense ratably over the vesting period of the participants. Future changes in the fair value of our common stock that is owed to the participants do not have any impact on the amounts recorded in our consolidated financial statements. During the three-month periods ended June 30, 2022 and 2021, we recognized $10.1 million and $7.6 million, respectively, to compensation expense related to restricted stock unit awards granted in 2016 through 2022. During the six-month periods ended June 30, 2022 and 2021, we recognized $17.7 million and $13.5 million, respectively, to compensation expense related to restricted stock unit awards granted in 2016 through 2022. The total intrinsic value of unvested restricted stock units at June 30, 2022 and 2021 was $353.1 million and $269.7 million, respectively. During the three-month periods ended June 30, 2022 and 2021, equity awards (including accrued dividends) with an aggregate value of $1.2 million and $1.3 million, respectively, were vested and distributed to employees under this plan. During the six-month periods ended June 30, 2022 and 2021, equity awards (including accrued dividends) with an aggregate value of $62.0 million and $48.1 million, respectively, were vested and distributed to employees under this plan.

Performance Share Awards

On March 15, 2022 and March 16, 2021, pursuant to the 2017 LTIP, the compensation committee approved 54,000 and 67,000, respectively, of provisional performance share awards, with an aggregate fair value of $8.6 million and $8.6 million, respectively, for future grants to our officers. Each performance share award was equivalent to the value of one share of our common stock on the date such provisional award was approved. At the end of the performance period, eligible participants will receive a number of earned shares based on the growth in adjusted EBITDAC per share (as defined in our 2022 Proxy Statement). Earned shares for the 2022 and 2021 provisional awards will fully vest based on continuous employment through March 15, 2025 and March 16, 2024, respectively, and will be settled in unrestricted shares of our common stock on a one-for-one basis as soon as practicable thereafter. The 2022 and 2021 awards are subject to a three-year performance period that began on January 1, 2022 and 2021, respectively, and vest on the three-year anniversary of the date of grant (March 15, 2025 and March 16, 2024). For certain of our executive officers age 55 or older, awards are no longer subject to forfeiture upon such officers’ departure from the company after two years from the date of grant. During the three-month periods ended June 30, 2022 and 2021, we recognized $3.7 million and $3.2 million, respectively, to compensation expense related to performance share awards granted in 2018 through 2022. During the six-month periods ended June 30, 2022 and 2021, we recognized $7.5 million and $6.2 million, respectively, to compensation expense related to performance share awards granted in 2018 through 2022. The total intrinsic value of unvested performance share awards at June 30, 2022 and 2021 was $54.2 million and $55.0 million, respectively. During the six-month periods ended June 30, 2022 and 2021, equity awards (including accrued dividends) with an aggregate fair value of $21.8 million and $19.1 million, respectively, were vested and distributed to employees under this plan.

Cash Awards

On March 15, 2022, pursuant to our Performance Unit Program (which we refer to as the Program), the compensation committee approved provisional cash awards of $19.9 million in the aggregate for future grants to our officers and key employees that are denominated in units (125,000 units in the aggregate), each of which was equivalent to the value of one share of our common stock on the date the provisional award was approved. The Program consists of a one-year performance period based on our financial performance and a three-year vesting period measured from January 1 of the year of grant. At the discretion of the compensation committee and determined based on our performance, the eligible officer or key employee will be granted a percentage of the provisional cash award units that equates to the EBITAC growth achieved (as defined in the Program). At the end of the performance period, eligible participants will be granted a number of units based on achievement of the performance goal and subject to approval by the compensation committee. Granted units for the 2022 provisional award will fully vest based on continuous employment through January 1, 2025. The ultimate award value will be equal to the trailing twelve-month price of our common stock on December 31, 2024, multiplied by the number of units subject to the award, but limited to between 0.5 and 1.5 times the original value of the units determined as of the grant date. The fair value of the awarded units will be paid out in cash as soon as practicable in 2025. If an eligible employee leaves us prior to the vesting date, the entire award will be forfeited. We did not recognize any compensation expense during the six-month period ended June 30, 2022 related to the 2022 provisional award under the Program.

On March 16, 2021, pursuant to the Program, the compensation committee approved provisional cash awards of $18.8 million in the aggregate for future grants to our officers and key employees that are denominated in units (147,000 units in the aggregate), each of which was equivalent to the value of one share of our common stock on the date the provisional award was approved. Terms of the 2021 provisional awards were similar to the terms of the 2022 provisional awards. Based on our performance for 2021, we granted 143,000 units under the Program in the first quarter of 2022 that will fully vest on January 1, 2024. During the three and six-month periods ended June 30, 2022, we recognized $2.9 million and $5.5 million, respectively, to compensation expense related to these awards.

On March 12, 2020, pursuant to the Program, the compensation committee approved provisional cash awards of $18.4 million in the aggregate for future grants to our officers and key employees that are denominated in units (213,000 units in the aggregate), each of which was equivalent to the value of one share of our common stock on the date the provisional award was approved. Terms of the 2020 provisional awards were similar to the terms of the 2022 provisional awards. Based on our performance for 2020, we granted 208,000 units under the Program in the first quarter of 2021 that will fully vest on January 1, 2023. During the three-month periods ended June 30, 2022 and 2021, we recognized $2.9 million and $2.3 million, respectively, to compensation expense related to these awards. During the six-month periods ended June 30, 2022 and 2021, we recognized $6.0 million and $5.2 million, respectively, to compensation expense related to these awards.

On March 14, 2019, pursuant to the Program, the compensation committee approved provisional cash awards of $16.5 million in the aggregate for future grants to our officers and key employees that are denominated in units (206,800 units in the aggregate), each of which was equivalent to the value of one share of our common stock on the date the provisional award was approved. Terms of the 2019 provisional awards were similar to the terms of the 2022 provisional awards. Based on our performance for 2019, we granted 200,000 units under the Program in the first quarter of 2020 that fully vested on January 1, 2022. During the three and six-month

periods ended June 30, 2021, we recognized $1.9 million and $5.1 million to compensation expense related to these awards, respectively.

During the six-month period ended June 30, 2022, cash awards related to the 2019 provisional award with an aggregate fair value of $21.1 million (177,000 units in the aggregate) were vested and distributed to employees under the program. During the six-month period ended June 30, 2021, cash awards related to the 2018 provisional award with an aggregate fair value of $17.7 million (176,300 units in the aggregate) were vested and distributed to employees under the Program.